U.S. Cardiac Rhythm Management Devices Market Size & Outlook
U.S. cardiac rhythm management devices market, 2018-2030 (US$M)
Related Markets
U.S. cardiac rhythm management devices market highlights
- The U.S. cardiac rhythm management devices market generated a revenue of USD 6,554.8 million in 2024 and is expected to reach USD 9,169.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5.8% from 2025 to 2030.
- In terms of segment, defibrillators was the largest revenue generating product in 2024.
- Defibrillators is the most lucrative product segment registering the fastest growth during the forecast period.
Cardiac rhythm management devices market data book summary
| Market revenue in 2024 | USD 6,554.8 million |
| Market revenue in 2030 | USD 9,169.8 million |
| Growth rate | 5.8% (CAGR from 2024 to 2030) |
| Largest segment | Defibrillators |
| Fastest growing segment | Defibrillators |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
| Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.2% of the global cardiac rhythm management devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. cardiac rhythm management devices market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,629.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cardiac Rhythm Management Devices Market Scope
Cardiac Rhythm Management Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. cardiac rhythm management devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 43.08% in 2024. Horizon Databook has segmented the U.S. cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
In addition, the FDA's regulatory review process facilitates innovation and advancements in CRMD technology. Manufacturers invest in R&D to meet FDA standards, leading to the introduction of novel CRMDs with enhanced features, improved performance, and better patient outcomes. FDA approvals incentivize continuous innovation, driving market growth and competitiveness.
In September 2023, Abbott received approval from the U.S. FDA for the dual-chamber leadless pacemaker system called the AVEIR DR. This is a significant development in the field of cardiac rhythm management, offering a minimally invasive option for people with abnormal or slow heart rhythms.
The U.S. makes the largest contribution to the North America market due to substantial developments and the presence of world-class hospitals. These hospitals are equipped with modern CRDMs, which are important for treating critical cardiac arrest.
Reasons to subscribe to U.S. cardiac rhythm management devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. cardiac rhythm management devices market databook
-
Our clientele includes a mix of cardiac rhythm management devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. cardiac rhythm management devices market, including forecasts for subscribers. This country databook contains high-level insights into U.S. cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. cardiac rhythm management devices industry size, by product, 2018-2030 (US$M)
U.S. Cardiac Rhythm Management Devices Market Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
